|
1 |
Anti-Inflammatory Drug Therapy in Aneurysmal Subarachnoid Hemorrhage
Wach, Johannes. - Basel : MDPI, 2025
|
|
|
|
2 |
Intermittent theta burst stimulation of the left dorsolateral prefrontal cortex has no additional effect on the efficacy of virtual reality exposure therapy for acrophobia. A randomized double-blind placebo-controlled study
Bohmeier, Barbara. - Würzburg : Universität Würzburg, 2025
|
|
|
|
3 |
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)
Rauber, Conrad. - Augsburg : Universität Augsburg, 2025
|
|
|
|
4 |
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
Flöge, Jürgen. - Aachen : Universitätsbibliothek der RWTH Aachen, 2025
|
|
|
|
5 |
Salivary cytokines in stress research : Reactivity kinetics in response to placebo-controlled acute psychosocial stress and associations with plasma cytokines and endocrine stress markers
Fischer, Marvin. - Konstanz : KOPS Universität Konstanz, 2025
|
|
|
6 |
GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction
Enthalten in Archiv der Pharmazie Bd. 358, 2025, Nr. 9. 16 S.
|
|
|
|
7 |
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials
Enthalten in Dermatology Bd. 241, 2025, Nr. 4: 325-335. 11 S.
|
|
|
|
8 |
Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials
Enthalten in Dermatology Bd. 241, 2025, Nr. 3: 272-286. 15 S.
|
|
|
|
9 |
Time to Loss of Disease Control following Guselkumab Withdrawal in Relation to Initial Speed of Response: A post hoc Analysis of the VOYAGE 2 Trial
Enthalten in Dermatology Bd. 241, 2025, Nr. 2: 133-142. 10 S.
|
|
|
|
10 |
Upadacitinib and Dupilumab Demonstrate Superior Efficacy in the Treatment of Adolescent Atopic Dermatitis: A Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 9: 896-906. 11 S.
|
|
Administration
